MedPath

Comparison of three different antibiotic treatments for skin borreliosis - erythema migrans.

Phase 1
Conditions
Erythema migrans (Early Lyme disease)
MedDRA version: 19.0Level: LLTClassification code 10015157Term: Erythema chronicum migransSystem Organ Class: 100000004862
Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
Registration Number
EUCTR2010-023747-15-NO
Lead Sponsor
niversity of Oslo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patient at a norwegian list holding general practitioner (GP) given the clinical diagnosis of erythema migrans. At least 18 years of age. Competent for an informed concent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 175
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 50

Exclusion Criteria

Severe symptoms suggesting systemic disease. Under 18 yeara. Pregnant or risk of pregnancy. Known allergy or intolerance of any of the studied antibiotics.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath